Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Acalabrutinib Versus Idelalisib Plus Rituximab (IdR) or Bendamustine Plus Rituximab (BR) in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): ASCEND Final Results
- Authors
- Ghia, Paolo; Pluta, Andrzej; Wach, Malgorzata; Lysak, Daniel; Kozak, Tomas; Simkovic, Martin; Kaplan, Polina; Kraychok, Iryna; Illes, Arpad; de la Serna, Javier; Dolan, Sean; Campbell, Philip; Musuraca, Gerardo; Jacob, Abraham; Avery, Eric J.; Lee, Jae Hoon; Wang, Denise; Patel, Priti; Jurczak, Wojciech
- Issue Date
- Sep-2020
- Publisher
- CIG MEDIA GROUP, LP
- Keywords
- CLL; chronic lymphocytic leukemia; phase 3
- Citation
- CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, v.20, pp.S220 - S221
- Journal Title
- CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
- Volume
- 20
- Start Page
- S220
- End Page
- S221
- ISSN
- 2152-2650
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Lee, Jae Hoon
- College of Medicine (Department of Medicine)